Please find attached an algorithm for determining the suitability of post-transfusion/infusion samples for mandatory screening for transmissible infections. Annex 5: Blood Components for Contingency UseĪppendix 3 - Calculation of Blood and Plasma Dilution Haemodilution algorithm Appendix 3 – Calculation of Blood & Plasma Dilution.Annex 2: ISBT 128 check character calculation.Annex 1: Standards available from the National Institute for Biological Standards and Control.27: Specification for labelling consumables used in therapeutic product production.26: Specification for blood pack base labels.25: Standards for electronic data interchange within the UK Blood Transfusion Services.24: Specification for the uniform labelling of human tissue products using ISBT 128.23: Specification for the uniform labelling of blood, blood components and blood donor samples.21: Tissue banking: tissue retrieval and processing.20: Tissue banking: selection of donors.15: Molecular typing for red cell antigens.14: Guidelines for the use of DNA/PCR techniques in Blood Establishments.13: Patient testing (red cell immunohaematology).12: Donation testing (red cell immunohaematology).10: Investigation of suspected transfusion-transmitted infection.9: Microbiology tests for donors and donations: general specifications for laboratory test procedures.8: Evaluation of novel blood components, production processes and blood packs: generic protocols.6: Evaluation and manufacture of blood components.5: Collection of a blood or component donation.4: Premises and quality assurance at blood donor sessions.

3: Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood).Quality in blood and tissue establishments and hospital blood banks

Microbiology dilutions worksheet